Postnatal dexamethasone, respiratory and neurodevelopmental outcomes at two years in babies born extremely preterm.

Gordon QinJessica W LoNeil MarlowSandy A CalvertAnne GreenoughJanet L Peacock

Published in: PloS one (2017)

Postnatal dexamethasone use in extremely preterm infants is associated with increased risks of respiratory hospital admissions and neurodevelopmental impairment. These associations were not explained by excess neonatal morbidities.

Keyphrases

preterm infants
low birth weight
gestational age
high dose
low dose
respiratory tract
preterm birth
human health
climate change